IMIDAZOLE DERIVATIVES OR SALTS THEREOF AND DRUGS CONTAINING THE DERIVATIVES OR THE SALTS
申请人:SSP Co., Ltd.
公开号:EP1295880A1
公开(公告)日:2003-03-26
The invention is directed to an imidazole derivative represented by formula (1):
wherein each of R1 and R2 represents an aryl group, a heteroaryl group, etc.; each of A, X1, and X2 represents N or CH; each of Y and Z represents O, S, etc.; each of R3, R4, and R5 represents a hydrogen atom, an alkyl group, etc.; m is a number of 1 to 4; and n is a number of 0 to 4, or a salt thereof. The invention is also directed to a drug containing the derivative or the salt as an active ingredient. These compounds exert excellent effects of inhibiting production of NO and IL-6 and are useful for preventing or treating diseases induced by overproduction of NO and IL-6.
本发明涉及由式(1)代表的咪唑衍生物:
其中R1和R2各自代表芳基、杂芳基等;A、X1和X2各自代表N或CH;Y和Z各自代表O、S等;R3、R4和R5各自代表氢原子、烷基等;m的数目为1至4;n的数目为0至4,或其盐。本发明还涉及一种含有衍生物或盐作为活性成分的药物。这些化合物具有抑制 NO 和 IL-6 生成的卓越效果,可用于预防或治疗因 NO 和 IL-6 生成过多而诱发的疾病。